SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-020743
Filing Date
2019-03-21
Accepted
2019-03-21 15:23:50
Documents
1
Period of Report
2019-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 22562
  Complete submission text file 0001209191-19-020743.txt   23933
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DR. SUITE 150 IRVING TX 75063
Business Address
Wilson Jason Douglas (Reporting) CIK: 0001662395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 19696884